• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Clinical Efficacy of Seasonal Influenza Vaccination - Characteristics of two Outbreaks of Influenza A(H1n1) in Immunocompromised Patients

tetano

Editor, Senior Moderator
J Hosp Infect. 2017 Dec 7. pii: S0195-6701(17)30652-7. doi: 10.1016/j.jhin.2017.12.003. [Epub ahead of print]
[h=1]The Clinical Efficacy of Seasonal Influenza Vaccination - Characteristics of two Outbreaks of Influenza A(H1n1) in Immunocompromised Patients.[/h] Helanter? I[SUP]1[/SUP], Janes R[SUP]2[/SUP], Anttila VJ[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza A(H1N1) causes serious complications in immunocompromised patients. The efficacy of seasonal vaccination in these patients has been questioned.
[h=4]AIMS:[/h] We describe two outbreaks of influenza A(H1N1) in immunocompromised patients.
[h=4]METHODS:[/h] Two outbreaks of influenza A(H1N1) occurred in our institution: on the kidney transplant ward in 2014 including patients early after kidney or simultaneous pancreas-kidney transplantation, and on the oncology ward in 2016 including patients receiving chemotherapy for malignant tumors. Factors leading to these outbreaks and the clinical efficacy of seasonal influenza vaccination were analyzed.
[h=4]FINDINGS:[/h] Altogether 86 patients were exposed to influenza A(H1N1) during the outbreaks, among whom the seasonal influenza vaccination status was unknown in ten. Only 3/38 vaccinated patients were infected with influenza A(H1N1), compared to 20/38 unvaccinated patients (P=0.02). 1/38 vaccinated patient died related to influenza, compared to 7/38 unvaccinated patients (P=0.06). Shared factors behind the two outbreaks included old fashioned facilities not designed for the treatment of immunosuppressed patients. Vaccination coverage among patients was low, between 40-70% despite vaccination being offered to all patients free of charge. Vaccination coverage of health care workers on the transplant ward was low (46%), but, despite high coverage on the oncology ward (92%) the outbreak occurred.
[h=4]CONCLUSIONS:[/h] Seasonal influenza vaccination was clinically effective with both a reduced risk of influenza infection and a trend towards reduced mortality in these immunocompromised patients. Several possible causes were identified behind these two outbreaks that require continuous awareness in health care professionals to prevent further outbreaks.
Copyright ? 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.


PMID: 29225054 DOI: 10.1016/j.jhin.2017.12.003
 
Back
Top Bottom